• Advancing the state of real-time MR guided neurotherapy.

Latest News

9/27/13

inseRT MRI Receives Phase I SBIR Award: inseRT MRI received formal notice of award from NIH National Cancer Initiative (NCI) on September 27, 2013 just five months after its Phase I submission. The process from submission to funding is normally at least a 12 month interval, but was accelerated due to the high quality of inseRT MRI's proposal and interest within the NCI on inseRT MRI's approach to guiding drug delivery in the brain.

5/14/14 inseRT Chief Technological Officer Ethan Brodsky Presents at the ISMRM Milan Meeting

Ethan Brodsky, PhD, gave an oral presentation at the International Society of Magnetic Resonance in Medicine (ISMRM) in Milan, Italy on the successful use of inseRT MRI technology to guide precisely guide the delivery of gene therapy into brains in vivo during preclinical studies. The studies aim to show the ability to change anxious temperament in survival animals. Brodsky presented work demonstrated sub-mm targeting accuracy of brain catheters as well as the ability to track infusions less than 10 microliters.

09/18/2014

inseRT MRI has been selected as one of eight Innovative Wisconsin companies to featured at the 2013 Bioscience Vision Summit.

Latest News

Last updated 2014-8-25

Our Work

Read more about our products.

Contact Us

Contact a company representative.